2101 Gaither Road
With offices in the US, Europe, and Asia, Medifacts International offers best-in-class science, technology, and service on a global basis in support of high-quality cardiac safety and efficacy data collection.
Medifacts primary mission is to support the acquisition of data necessary to determine the safety and/or efficacy of drugs or devices involved in clinical trials. Medifacts has been instrumental in shaping the industry by setting standards of quality and unsurpassed service. Today, as cardiovascular experts with international reach, Medifacts continues to lead the industry by upholding a high standard of excellence.
With over 23 years of experience and offices Medifacts is a global leader in cardiac safety monitoring services. Medifacts' cardiac safety services include:
• Ambulatory Blood Pressure Monitoring (ABPM)
• Home and Office Blood Pressure Monitoring
• Other modalities (Spirometry, Echocardiography…)
• Arterial compliance monitoring
• Diagnostic telemonitoring
In support of these services, Medifacts offers:
• Global presence with offices on 3 continents
• Project management
• Site support (24x7x365)
• Comprehensive, hands-on training of equipment and procedures offered on-site, at Investigator meetings, or via teleconference
• Equipment provision
• Full ‘gold standard’ ECG analysis
With unrivalled scientific leadership, Medifacts provides a full range of consultancy and analysis services throughout the development lifecycle and beyond. Consulting services include:
• Expert feedback in program and protocol design
• Protocol writing
• Interim summary reports
• Biostatistics and expert reports
• Final report writing
Medifacts has developed a pioneering technology infrastructure (the WebHeart® platform) which, coupled with scientific expertise and experienced and dedicated staff, has allowed Medifacts to emerge as one of the top service providers in the world.
WebHeart® is a proprietary, global, Web-based platform that offers a complete solution to acquiring, displaying, measuring, and managing Cardiac Safety data in clinical trials. This system allows for real-time access to ECG and Ambulatory Blood Pressure data. Because no actual programming is needed, the time and cost of both study setup and data submission are dramatically reduced. All ECG data can be converted into an XML format that meets FDA requirements and protocol setups are easily configured and expanded to accommodate additional information.
Medifacts International’s scientific expertise, proprietary WebHeart® technology, global presence and quality leadership are recognized throughout the industry as Medifacts is increasingly selected as the partner of choice by pharmaceutical and biotech drug developers.